Pfizer Inc
NYSE: PFE
$26.43
+$0.33 (+1.3%)
Closing Price on February 28, 2025
PFE Articles
Standard & Poor's has now shown that the first quarter of 2016 saw a 12% rise in buyback spending to a whopping $161.4 billion.
Published:
Last Updated:
June 21, 2016: Markets opened higher again Tuesday ahead of Fed chairwoman Janet Yellen’s appearance on Capitol Hill. The odds continue to improve that British voters will not choose to leave the...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include Chesapeake Energy, Motorola Solutions, Pfizer, Spirit Air, Symantec, Under Armour and US Foods.
Published:
Last Updated:
June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed president James Bullard suggested that interest rate hikes may be far less...
Published:
Last Updated:
June 15, 2016: Markets opened higher Wednesday on hopes that the the FOMC meeting would leave interest rates unchanged, the outcome most people expected and the actual outcome as it turned out. More...
Published:
Last Updated:
Pfizer made waves early on Tuesday after it announced a new licensing deal with Shire for an investigational biologic.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
June 8, 2016: Markets opened higher for a third straight day Wednesday boosted by rising crude oil prices and a falling dollar. An premarket jump in shares of LendingClub helped out until the opening...
Published:
Last Updated:
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking for.
Published:
Last Updated:
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Published:
Last Updated:
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
Published:
Last Updated:
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
However, one medical supply company stood out, as short sellers piled on Baxter International in the first two weeks of the month.
Published:
Last Updated:
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these...
Published:
Last Updated:
Pfizer has announced that it has reached a definitive agreement to acquire Anacor Pharmaceuticals in a deal valued at more than $5 billion.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.